what are glp-1 weight loss drugs Professor Receives Grant to Study Effectiveness of Weight-Loss Market Overview: GLP-1 Agonists and

I have a couple theories as to why this is happening

Obesity Science & Practice, 3 (1), 314

Diabetes mellitus: complications and therapeutics

Ozempic is a brand name for a drug called semaglutide, which is a GLP-1 receptor agonist

GLP-1RA and GIP/GLP-1RA, although structurally similar to endogenous incretins, are resistant to inactivation by DPP-4, which prolongs their effects (Figure 1)

The original MDL for Victoza began in 2013, but most federal claims linking Victoza to pancreatic and thyroid cancer were dismissed in 2021, and the MDL was formally dismissed in 2022 due to insufficient evidence from the plaintiffs sole expert witness